Systemic corticosteroids in acute exacerbation of COPD: a meta-analysis of controlled studies with emphasis on ICU patients

Annals of Intensive Care

Volumn 4, Issue 1, 2014, Pages

  Abroug, Fekri ^a   Ouanes, Islem ^a   Abroug, Sarra ^a   Dachraoui, Fahmi ^a   Abdallah, Saoussen Ben ^a   Hammouda, Zeineb ^a   Ouanes Besbes, Lamia ^a  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

COPD; Corticosteroids; Critical care; Exacerbation

Indexed keywords

CORTICOSTEROID; PLACEBO;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; DISEASE EXACERBATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; ENDOTRACHEAL INTUBATION; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFECTION; INSULIN TREATMENT; INTENSIVE CARE; MENTAL DISEASE; META ANALYSIS; MORTALITY; NONINVASIVE VENTILATION; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; SYSTEMATIC REVIEW; SYSTEMIC THERAPY;

EID: 84919941471     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/s13613-014-0032-x     Document Type: Article

References (41)

1. Global Strategy for the Diagnosis MaPoC: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. [www.goldcopd.org]
2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Abdulhal A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, et al: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet 2012, 380:2095–2128.
3. Wedzicha JA, Wilkinson T: Impact of chronic obstructive pulmonary disease exacerbations on patients and payers.Proc Am Thorac Soc 2006, 3:218–221.
4. Guarascio AJ, Ray SM, Finch CK, Self TH: The clinical and economic burden of chronic obstructive pulmonary disease in the USA.Clinicoecon Outcomes Res 2013, 5:235–245.
5. Chandra D, Stamm JA, Taylor B, Ramos RM, Satterwhite L, Krishnan JA, Mannino D, Sciurba FC, Holguin F: Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998–2008.Am J Respir Crit Care Med 2012, 185:152–159.
6. Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA: Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease.JAMA 1995, 274:1852–1857.
7. Wedzicha JA: Airway infection accelerates decline of lung function in chronic obstructive pulmonary disease.Am J Respir Crit Care Med 2001, 164:1757–1758.
8. Barnes PJ: Chronic obstructive pulmonary disease.N Engl J Med 2000, 343:269–280.
9. Wedzicha JA, Seemungal TA: COPD exacerbations: defining their cause and prevention.Lancet 2007, 370:786–796.
10. Decramer M, Janssens W, Miravitlles M: Chronic obstructive pulmonary disease.Lancet 2012, 379:1341–1351.
11. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD: The nature of small-airway obstruction in chronic obstructive pulmonary disease.N Engl J Med 2004, 350:2645–2653.
12. Celli BR, MacNee W, Force AET: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.Eur Respir J 2004, 23:932–946.
13. O’Donnell DE, Aaron S, Bourbeau J, Hernandez P, Marciniuk DD, Balter M, Ford G, Gervais A, Goldstein R, Hodder R, Maltais F, Road J, McKay V, Schenkel J, Ariel A, Day A, Lacasse Y, Levy R, Lien D, Miller J, Rocker G, Sinuff T, Stewart P, Voduc N, Abboud R, Becklake M, Borycki E, Brooks D, Bryan S, Calcutt L, et al: Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.Can Respir J 2007, 14(Suppl B):5B–32B.
14. Bach PB, Brown C, Gelfand SE, McCrory DC: Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence.Ann Intern Med 2001, 134:600–620.
15. Walters JA, Gibson PG, Wood-Baker R, Hannay M, Walters EH: Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.Cochrane Database Syst Rev 2009, CD001288. doi:10.1002/14651858.CD001288.pub3.
16. Cheng T, Gong Y, Guo Y, Cheng Q, Zhou M, Shi G, Wan H: Systemic corticosteroid for COPD exacerbations, whether the higher dose is better? A meta-analysis of randomized controlled trials.Clin Respir J 2013, 7:305–318.
17. Singh JM, Palda VA, Stanbrook MB, Chapman KR: Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review.Arch Intern Med 2002, 162:2527–2536.
18. Chang KC, Leung CC, Kong FY: Corticosteroid administration and treatment failure in acute exacerbation of chronic obstructive pulmonary disease.JAMA 2010, 304:1554. author reply 1554–1556.
19. Kiser TH, Allen RR, Valuck RJ, Moss M, Vandivier RW: Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease.Am J Respir Crit Care Med 2014, 189:1052–1064.
20. Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB: Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease.JAMA 2010, 303:2359–2367.
21. Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T, Duerring U, Henzen C, Leibbrandt Y, Maier S, Miedinger D, Muller B, Scherr A, Schindler C, Stoeckli R, Viatte S, von Garnier C, Tamm M, Rutishauser J: Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.JAMA 2013, 309:2223–2231.
22. Walters JA, Wang W, Morley C, Soltani A, Wood-Baker R: Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.Cochrane Database Syst Rev 2011, CD005374. doi:10.1002/14651858.CD006897.pub2.
23. Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, Anderson P, Morgan NA: Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.N Engl J Med 1999, 340:1941–1947.
24. Amaya-Villar R, Garnacho-Montero J, Garcia-Garmendia JL, Madrazo-Osuna J, Garnacho-Montero MC, Luque R, Ortiz-Leyba C: Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease.Intensive Care Med 2005, 31:157–161.
25. Chakrabarti B, Angus RM, Agarwal S, Lane S, Calverley PMA: Hyperglycaemia as a predictor of outcome during non-invasive ventilation in decompensated COPD.Thorax 2009, 64:857–862.
26. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.Ann Intern Med 1987, 106:196–204.
27. Jadad ARMR, Carroll D: Assessing the quality of reports of randomized clinical trials: is blinding necessary?Control Clin Trials 1996, 17:1–12.
28. Emerman CL, Connors AF, Lukens TW, May ME, Effron D: A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD.Chest 1989, 95:563–567.
29. Albert RK, Martin TR, Lewis SW: Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency.Ann Intern Med 1980, 92:753–758.
30. Bullard MJ, Liaw SJ, Tsai YH, Min HP: Early corticosteroid use in acute exacerbations of chronic airflow obstruction.Am J Emerg Med 1996, 14:139–143.
31. Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ: Controlled trial of oral prednisone in outpatients with acute COPD exacerbation.Am J Respir Crit Care Med 1996, 154:407–412.
32. Wood-Baker RWJ, Pearce M, Ryan G: A double-blind, randomised, placebo-controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract].Aust NZ J Med 1997, 28:21.
33. Davies L, Angus RM, Calverley PM: Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.Lancet 1999, 354:456–460.
34. Maltais F, Ostinelli J, Bourbeau J, Tonnel AB, Jacquemet N, Haddon J, Rouleau M, Boukhana M, Martinot JB, Duroux P: Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.Am J Respir Crit Care Med 2002, 165:698–703.
35. Aaron SD, Vandemheen KL, Hebert P, Dales R, Stiell IG, Ahuja J, Dickinson G, Brison R, Rowe BH, Dreyer J, Yetisir E, Cass D, Wells G: Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.N Engl J Med 2003, 348:2618–2625.
36. Chen G, Xie CM, Luo YF: [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases].Zhonghua Jie He He Hu Xi Za Zhi 2008, 31:577–580.
37. Alia I, de la Cal MA, Esteban A, Abella A, Ferrer R, Molina FJ, Torres A, Gordo F, Elizalde JJ, de Pablo R, Huete A, Anzueto A: Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support.Arch Intern Med 2011, 171:1939–1946.
38. Abroug F, Ouanes-Besbes L, Fkih-Hassen M, Ouanes I, Ayed S, Dachraoui F, Brochard L, Elatrous S: Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation.Eur Respir J 2014, 43:717–724.
39. Shorr AF, Chan CM: Clinical trials in the critically ill: practical and ethical challenges: comment on “Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support”.Arch Intern Med 2011, 171:1946–1947.
40. Ram FS, Picot J, Lightowler J, Wedzicha JA: Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease.Cochrane Database Syst Rev 2004, CD004104. doi:10.1002/14651858.CD004104.pub3.
41. Sun X, Ioannidis JP, Agoritsas T, Alba AC, Guyatt G: How to use a subgroup analysis: users’ guide to the medical literature.JAMA 2014, 311:405–411.